Breast Cancer Clinical Trial
Official title:
Home-Based Symptom Management Via Reflexology for Breast Cancer Patients
The purpose of this project is to test foot reflexology delivered by a friend or family member in the home for women with breast cancer. The primary aims of the proposed study in a sample of women with breast cancer receiving chemotherapy and/or hormonal therapy are to determine the effects of 4 family- or friend-delivered weekly reflexology sessions compared to an attention control group.
This project tests the benefits of a home-based intervention of foot reflexology for
improving health-related quality of life (HRQOL) including symptom responses, functioning,
and health perceptions in women treated with chemotherapy for advanced breast cancer.
Reflexology applies a firm walking-motion during sessions and is based on the premise that
the foot has reflexes mirroring organs of the body. Symptom burden is the strongest predictor
of HRQOL for cancer patients. This project brings together expertise from nursing,
reflexology, communication, statistics, and health economics. The primary specific aims, in a
sample of women with advanced breast cancer receiving chemotherapy, are to determine the
effects of a 4-week, home-based reflexology intervention delivered by a friend/family
provider compared to attention control for improvement of:
1. HRQOL including symptoms, functioning, and health perception at study weeks 5 and 11.
The investigators hypothesize that the reflexology group will have better HRQOL
(symptoms, functioning, and health perception) than the attention control group at study
weeks 5 and 11.
2. Multiple symptom responses and times-to-response as determined by weekly symptom
assessments during the 4-week intervention time.
The investigators hypothesize that the reflexology group will have a higher proportion
of symptoms that respond to the intervention and shorter time-to-symptom-responses than
the attention control group.
3. Symptom-related use of unscheduled health services during the 11-week study. The
investigators hypothesize that fewer unscheduled services will be used for symptom
management over the 11-week study period by women receiving reflexology compared to
women in the attention control.
The exploratory aims are to: 1) Explore differences between trial arms in perceptions of
social support due to the family- or friend-delivered reflexology sessions at study weeks 5
and 11; 2) Determine if effects of the reflexology intervention on HRQOL are mediated by
social support; and 3) Use the newly developed NIH PROMIS standardized symptom and
functioning instruments to assess the effects of the reflexology intervention and to compare
the responsiveness of PROMIS instruments and existing instruments designed to measure similar
constructs.
This project has immense potential to make an effective symptom management intervention
accessible to patients in their homes via a friend or family home provider. The investigators
will not only intervene to enhance HRQOL but also to evaluate social support and costs
associated with unscheduled health services. Effective symptom management provides time and
cost savings to clinicians, advances the current state-of-the-science, and promotes adherence
to medical treatment that may ultimately enhance survival.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |